Global Anti-aging Services & Devices Market Forecast 2024-2032

The global anti-aging services & devices market is expected to register a CAGR of 11.03% during the forecast period, 2024-2032. The market growth is attributed to the preventive approach and early adoption of anti-aging treatments among younger generations, the growing aging population, and the demand for minimally invasive and non-invasive treatments.

MARKET INSIGHTS

Anti-aging services and devices are essential in addressing the bio-physiological changes associated with aging, impacting the layers of the skin and giving rise to wrinkles, fine lines, and diminished firmness. The market for anti-aging products and devices is witnessing a surge, providing a lucrative platform for cosmetologists and healthcare professionals. These devices, whether mechanical or electronic, aim to offer non-invasive or minimally invasive treatments to eliminate, reduce, delay, or prevent signs of aging.

Anti-aging treatments among younger generations underscore a heightened awareness of the efficacy of early interventions in preserving youthful skin, representing a fundamental change in skincare habits from reactive to preventive practices. Simultaneously, the market benefits from a rising aging population worldwide, fostering increased demand for targeted solutions to address age-related skincare concerns. The market responds with a diverse array of anti-aging treatments and devices, catering to the specific needs of an aging demographic as individuals seek effective measures to maintain a youthful appearance.

Insufficient clinical data poses a challenge to establishing the efficacy and safety of anti-aging treatments, hindering market growth. The absence of reimbursement policies for aesthetic treatments creates accessibility barriers, especially for specific demographics. Consumer apprehension about potential side effects adds to these challenges. Despite obstacles, ongoing innovation fuels the dynamic evolution of the anti-aging services & devices market.

REGIONAL INSIGHTS

The global anti-aging services & devices market growth analysis is conducted based on the geographical segmentation of North America, Europe, Asia-Pacific, and Rest of World. North America is the largest revenue-generating region in the global market, attributed to easy access to technology and heightened public awareness.

COMPETITIVE INSIGHTS

The global anti-aging services & devices market experiences intense industry rivalry, marked by fierce competition as numerous companies seek to stand out through branding and technology. This drive for differentiation is fueled by the significant demand for innovative solutions within the anti-aging & devices market. Some of the leading companies in the market are Merz Pharma, AbbVie, Candela Medical, Cutera Inc, ElEn SpA, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 75176

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON ANTI-AGING SERVICES & DEVICES MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. FAVOURABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
- 2.5.2. SMART TECHNOLOGY IS NOW A BIG PART OF BEAUTY INDUSTRY
- 2.5.3. INFLATING COSMETIC TOURISM RISE THE DEMAND FOR ANTI-AGING SERVICES & DEVICES

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVENTIVE APPROACH AND EARLY ADOPTION OF ANTI-AGING TREATMENTS AMONG YOUNGER GENERATIONS
- 3.1.2. GROWING AGING POPULATION
- 3.1.3. DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE TREATMENTS
3.2. KEY RESTRAINTS
- 3.2.1. INSUFFICIENT CLINICAL DATA
- 3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING AESTHETIC TREATMENTS
- 3.2.3. CONCERNS REGARDING THE SIDE EFFECTS OF AESTHETIC TREATMENTS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN ADOPTION OF HANDHELD ANTI-AGING DEVICES
- 4.1.2. RISE IN MEDICAL TOURISM
- 4.1.3. PERSONALIZATION AND CUSTOMIZATION IN ANTI-AGING SERVICES & DEVICES
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
- 4.3.2. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
- 4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
- 4.3.4. GROWTH PROSPECT MAPPING FOR BRAZIL
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
- 4.6.1. RAW MATERIAL SOURCING
- 4.6.2. MANUFACTURING AND PRODUCTION
- 4.6.3. DISTRIBUTORS AND LOGISTICS
- 4.6.4. RETAILERS AND END-USERS
4.7. KEY BUYING CRITERIA
- 4.7.1. COST
- 4.7.2. TECHNOLOGY
- 4.7.3. USABILITY
- 4.7.4. BRAND NAME

5. MARKET BY AGE GROUP

5.1. 18-34 YEARS OLD
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. 35-50 YEARS OLD
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. 51-64 YEARS OLD
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS
5.4. 65 YEARS OR OLDER
- 5.4.1. MARKET FORECAST FIGURE
- 5.4.2. SEGMENT ANALYSIS

6. MARKET BY USER DEMOGRAPHIC

6.1. MALE
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. FEMALE
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS

7. MARKET BY DEVICE TYPE

7.1. PROFESSIONAL STAND-ALONE DEVICE
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. DIRECT-TO-CONSUMER DEVICE
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS

8. MARKET BY TREATMENT

8.1. ANTI-CELLULITE TREATMENT
- 8.1.1. MARKET FORECAST FIGURE
- 8.1.2. SEGMENT ANALYSIS
8.2. ANTI-WRINKLE TREATMENT
- 8.2.1. MARKET FORECAST FIGURE
- 8.2.2. SEGMENT ANALYSIS
8.3. ANTI-PIGMENTATION TREATMENT
- 8.3.1. MARKET FORECAST FIGURE
- 8.3.2. SEGMENT ANALYSIS
8.4. SKIN RESURFACING TREATMENT
- 8.4.1. MARKET FORECAST FIGURE
- 8.4.2. SEGMENT ANALYSIS
8.5. OTHER TREATMENTS
- 8.5.1. MARKET FORECAST FIGURE
- 8.5.2. SEGMENT ANALYSIS

9. MARKET BY DEVICE

9.1. EXFOLIATION DEVICE
- 9.1.1. MARKET FORECAST FIGURE
- 9.1.2. SEGMENT ANALYSIS
9.2. LASER DEVICE
- 9.2.1. MARKET FORECAST FIGURE
- 9.2.2. SEGMENT ANALYSIS
9.3. LED/LIGHT THERAPY DEVICE
- 9.3.1. MARKET FORECAST FIGURE
- 9.3.2. SEGMENT ANALYSIS
9.4. MICRODERMABRASION DEVICE
- 9.4.1. MARKET FORECAST FIGURE
- 9.4.2. SEGMENT ANALYSIS
9.5. MICRONEEDLING DEVICE
- 9.5.1. MARKET FORECAST FIGURE
- 9.5.2. SEGMENT ANALYSIS
9.6. NANO-CURRENT & MICRO-CURRENT DEVICE
- 9.6.1. MARKET FORECAST FIGURE
- 9.6.2. SEGMENT ANALYSIS
9.7. PULSED LIGHT DEVICE
- 9.7.1. MARKET FORECAST FIGURE
- 9.7.2. SEGMENT ANALYSIS
9.8. RADIOFREQUENCY DEVICE
- 9.8.1. MARKET FORECAST FIGURE
- 9.8.2. SEGMENT ANALYSIS
9.9. ULTRASOUND DEVICE
- 9.9.1. MARKET FORECAST FIGURE
- 9.9.2. SEGMENT ANALYSIS
9.10. OTHER DEVICES
- 9.10.1. MARKET FORECAST FIGURE
- 9.10.2. SEGMENT ANALYSIS

10. MARKET BY END-USER

10.1. DERMATOLOGY CLINICS
- 10.1.1. MARKET FORECAST FIGURE
- 10.1.2. SEGMENT ANALYSIS
10.2. HOSPITALS
- 10.2.1. MARKET FORECAST FIGURE
- 10.2.2. SEGMENT ANALYSIS
10.3. REJUVENATION CENTERS
- 10.3.1. MARKET FORECAST FIGURE
- 10.3.2. SEGMENT ANALYSIS
10.4. HOME USE
- 10.4.1. MARKET FORECAST FIGURE
- 10.4.2. SEGMENT ANALYSIS

11. GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
- 11.1.1. MARKET SIZE & ESTIMATES
- 11.1.2. NORTH AMERICA ANTI-AGING SERVICES & DEVICES MARKET DRIVERS
- 11.1.3. NORTH AMERICA ANTI-AGING SERVICES & DEVICES MARKET CHALLENGES
- 11.1.4. NORTH AMERICA ANTI-AGING SERVICES & DEVICES MARKET REGULATORY FRAMEWORK
- 11.1.5. KEY PLAYERS IN NORTH AMERICA ANTI-AGING SERVICES & DEVICES MARKET
- 11.1.6. COUNTRY ANALYSIS
  - 11.1.6.1. UNITED STATES
  - 11.1.6.1.1. UNITED STATES ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.1.6.2. CANADA
  - 11.1.6.2.1. CANADA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
11.2. EUROPE
- 11.2.1. MARKET SIZE & ESTIMATES
- 11.2.2. EUROPE ANTI-AGING SERVICES & DEVICES MARKET DRIVERS
- 11.2.3. EUROPE ANTI-AGING SERVICES & DEVICES MARKET CHALLENGES
- 11.2.4. EUROPE ANTI-AGING SERVICES & DEVICES MARKET REGULATORY FRAMEWORK
- 11.2.5. KEY PLAYERS IN EUROPE ANTI-AGING SERVICES & DEVICES MARKET
- 11.2.6. COUNTRY ANALYSIS
  - 11.2.6.1. UNITED KINGDOM
  - 11.2.6.1.1. UNITED KINGDOM ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.2. GERMANY
  - 11.2.6.2.1. GERMANY ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.3. FRANCE
  - 11.2.6.3.1. FRANCE ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.4. ITALY
  - 11.2.6.4.1. ITALY ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.5. SPAIN
  - 11.2.6.5.1. SPAIN ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.6. BELGIUM
  - 11.2.6.6.1. BELGIUM ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.7. POLAND
  - 11.2.6.7.1. POLAND ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.2.6.8. REST OF EUROPE
  - 11.2.6.8.1. REST OF EUROPE ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
11.3. ASIA-PACIFIC
- 11.3.1. MARKET SIZE & ESTIMATES
- 11.3.2. ASIA-PACIFIC ANTI-AGING SERVICES & DEVICES MARKET DRIVERS
- 11.3.3. ASIA-PACIFIC ANTI-AGING SERVICES & DEVICES MARKET CHALLENGES
- 11.3.4. ASIA-PACIFIC ANTI-AGING SERVICES & DEVICES MARKET REGULATORY FRAMEWORK
- 11.3.5. KEY PLAYERS IN ASIA-PACIFIC ANTI-AGING SERVICES & DEVICES MARKET
- 11.3.6. COUNTRY ANALYSIS
  - 11.3.6.1. CHINA
  - 11.3.6.1.1. CHINA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.2. JAPAN
  - 11.3.6.2.1. JAPAN ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.3. INDIA
  - 11.3.6.3.1. INDIA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.4. SOUTH KOREA
  - 11.3.6.4.1. SOUTH KOREA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.5. SINGAPORE
  - 11.3.6.5.1. SINGAPORE ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.6. THAILAND
  - 11.3.6.6.1. THAILAND ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.7. MALAYSIA
  - 11.3.6.7.1. MALAYSIA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.8. AUSTRALIA & NEW ZEALAND
  - 11.3.6.8.1. AUSTRALIA & NEW ZEALAND ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.3.6.9. REST OF ASIA-PACIFIC
  - 11.3.6.9.1. REST OF ASIA-PACIFIC ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
11.4. REST OF WORLD
- 11.4.1. MARKET SIZE & ESTIMATES
- 11.4.2. REST OF WORLD ANTI-AGING SERVICES & DEVICES MARKET DRIVERS
- 11.4.3. REST OF WORLD ANTI-AGING SERVICES & DEVICES MARKET CHALLENGES
- 11.4.4. REST OF WORLD ANTI-AGING SERVICES & DEVICES MARKET REGULATORY FRAMEWORK
- 11.4.5. KEY PLAYERS IN REST OF WORLD ANTI-AGING SERVICES & DEVICES MARKET
- 11.4.6. REGIONAL ANALYSIS
  - 11.4.6.1. LATIN AMERICA
  - 11.4.6.1.1. LATIN AMERICA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES
  - 11.4.6.2. MIDDLE EAST & AFRICA
  - 11.4.6.2.1. MIDDLE EAST & AFRICA ANTI-AGING SERVICES & DEVICES MARKET SIZE & OPPORTUNITIES

12. COMPETITIVE LANDSCAPE

12.1. KEY STRATEGIC DEVELOPMENTS
- 12.1.1. MERGERS & ACQUISITIONS
- 12.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
12.2. COMPANY PROFILES
- 12.2.1. ABBVIE
  - 12.2.1.1. COMPANY OVERVIEW
  - 12.2.1.2. PRODUCT LIST
  - 12.2.1.3. STRENGTHS & CHALLENGES
- 12.2.2. CANDELA MEDICAL
  - 12.2.2.1. COMPANY OVERVIEW
  - 12.2.2.2. PRODUCT LIST
  - 12.2.2.3. STRENGTHS & CHALLENGES
- 12.2.3. CUTERA INC
  - 12.2.3.1. COMPANY PROFILE
  - 12.2.3.2. PRODUCT LIST
  - 12.2.3.3. STRENGTHS & CHALLENGES
- 12.2.4. CYNOSURE
  - 12.2.4.1. COMPANY PROFILE
  - 12.2.4.2. PRODUCT LIST
- 12.2.5. DAEWOONG PHARMACEUTICAL CO LTD
  - 12.2.5.1. COMPANY PROFILE
  - 12.2.5.2. PRODUCT LIST
  - 12.2.5.3. STRENGTHS & CHALLENGES
- 12.2.6. ELEN SPA
  - 12.2.6.1. COMPANY OVERVIEW
  - 12.2.6.2. PRODUCT LIST
  - 12.2.6.3. STRENGTHS & CHALLENGES
- 12.2.7. EVOLUS INC
  - 12.2.7.1. COMPANY OVERVIEW
  - 12.2.7.2. PRODUCT LIST
  - 12.2.7.3. STRENGTHS & CHALLENGES
- 12.2.8. FOREO
  - 12.2.8.1. COMPANY OVERVIEW
  - 12.2.8.2. PRODUCT LIST
- 12.2.9. GALDERMA
  - 12.2.9.1. COMPANY OVERVIEW
  - 12.2.9.2. PRODUCT LIST
  - 12.2.9.3. STRENGTHS & CHALLENGES
- 12.2.10. HUGEL INC
  - 12.2.10.1. COMPANY OVERVIEW
  - 12.2.10.2. PRODUCT LIST
  - 12.2.10.3. STRENGTHS & CHALLENGES
- 12.2.11. LUMENIS LTD
  - 12.2.11.1. COMPANY OVERVIEW
  - 12.2.11.2. PRODUCT LIST
  - 12.2.11.3. STRENGTHS & CHALLENGES
- 12.2.12. MEDYTOX INC
  - 12.2.12.1. COMPANY OVERVIEW
  - 12.2.12.2. PRODUCT LIST
  - 12.2.12.3. STRENGTHS & CHALLENGES
- 12.2.13. INMODE LTD
  - 12.2.13.1. COMPANY OVERVIEW
  - 12.2.13.2. PRODUCT LIST
- 12.2.14. MERZ PHARMA
  - 12.2.14.1. COMPANY OVERVIEW
  - 12.2.14.2. PRODUCT LIST
  - 12.2.14.3. STRENGTHS & CHALLENGES
- 12.2.15. REVANCE THERAPEUTICS INC
  - 12.2.15.1. COMPANY OVERVIEW
  - 12.2.15.2. PRODUCT LIST